Verras Ltd. Acquired by group of investors as Delaware Corporation.
Developed Health Outcomes Prediction System (HOPS) for quality and cost efficiency predictions across the entire continuum of care. (Patent is current.)
Developed and patented the Acuity Index Method (inpatient, severity of illness adjustment) (Patent is current.)
Verras Chief Medical Officer Dr. Bill Mohlenbrock is scheduled to discuss the distribution of global payments based on quality metrics…Read More »
Dr. Mohlenbrock will be presenting at 3:15pm on Friday, May 18, and will be speaking on the topic of "Clinical…Read More »
For Immediate Release Contact: John Malone, President, Verras Healthcare International Phone: 312.422.1810 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Verras Launches Verras Watson™ to Uncover…Read More »